FRIDAY, Oct. 11, 2024 (HealthDay News) — The key to weight loss could come down to a combination of 14 “skinny genes,” a recent study says. People with these genes dropped twice as much weight through regular exercise compared to those without the genes, researchers found. Those with the mostContinue Reading
WEDNESDAY, Oct. 9, 2024 (HealthDay News) — When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows. In a report published Wednesday in the journal Health Affairs,Continue Reading
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Most Americans are eating their way to inflammation that puts them at risk of cancer, heart disease and other serious health problems, a new study shows. “Overall, 57% of U.S. adults have a pro-inflammatory diet and that number was higher for Black Americans,Continue Reading
TUESDAY, Oct. 1, 2024 (HealthDay News) — Food left in the stomach or stool left in the bowel can impede a doctor’s ability to successfully perform an endoscopy or colonoscopy. Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as Ozempic,Continue Reading
-690x550.jpg)
THURSDAY, Sept. 26, 2024 (HealthDay News) — There’s good news for folks who struggle to fit regular exercise into their busy workweek. “Weekend warrior” workouts are just as beneficial as daily exercise to a person’s overall health, a new study says. People who get all their weekly recommended exercise inContinue Reading
THURSDAY, Sept. 26, 2024 (HealthDay News) — “Body roundness” could be a better measure than BMI at predicting how excess weight might affect a person’s heart health, a new study finds. People who developed a high Body Roundness Index during a six-year period had a 163% increased risk of heartContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose. People with type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower riskContinue Reading
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster drugs Ozempic and Wegovy. While testifying before the Senate Committee on Health, Education, Labor and Pensions,Continue Reading
TUESDAY, Sept. 24, 2024 (HealthDay News) — Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows. Obesity rates fluctuated with age and fell as levels of education increased, said the report from the U.S. Centers for DiseaseContinue Reading
FRIDAY, Sept. 20, 2024 (HealthDay News) — Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates. A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because theyContinue Reading
WEDNESDAY, Sept. 17, 2024 (HealthDay News) — Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without insurance coverage. Because of these barriers, many people are doing an end-run around their doctor’s office, reaching outContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, veterans with diabetes and what’s known as metabolic dysfunction-associated steatotic liverContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds. Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of peopleContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds. Overweight or obese type 1 diabetics taking Mounjaro were able to reduce theContinue Reading